Cargando…
NAT2 variants and toxicity related to anti-tuberculosis agents: a systematic review and meta-analysis
BACKGROUND: Tuberculosis (TB) patients receiving anti-tuberculosis treatment may experience serious adverse drug reactions (ADRs) such as hepatotoxicity. Variants of the N-acetyltransferase 2 (NAT2) gene may increase the risk of experiencing such toxicity events. OBJECTIVE: To provide a comprehensiv...
Autores principales: | Richardson, M., Kirkham, J., Dwan, K., Sloan, D. J., Davies, G., Jorgensen, A. L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Union Against Tuberculosis and Lung Disease
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6421944/ https://www.ncbi.nlm.nih.gov/pubmed/30871660 http://dx.doi.org/10.5588/ijtld.18.0324 |
Ejemplares similares
-
CYP genetic variants and toxicity related to anti-tubercular agents: a systematic review and meta-analysis
por: Richardson, Marty, et al.
Publicado: (2018) -
Influence of genetic variants on toxicity to anti-tubercular agents: a systematic review and meta-analysis (protocol)
por: Richardson, Marty, et al.
Publicado: (2017) -
Protocol for the development of the STrengthening the Reporting Of Pharmacogenetic Studies (STROPS) guideline: checklist of items for reporting pharmacogenetic studies
por: Richardson, Marty, et al.
Publicado: (2019) -
Prevention of isoniazid toxicity by NAT2 genotyping in Senegalese tuberculosis patients
por: Toure, A., et al.
Publicado: (2016) -
STrengthening the Reporting Of Pharmacogenetic Studies: Development of the STROPS guideline
por: Chaplin, Marty, et al.
Publicado: (2020)